Medical Marijuana Inc's PhytoSPHERE Systems Reports it Has Radically Increased
Hemp Production in Expectation of World Wide Demand for 2013 & 2014
Major New Worldwide Production to Add to Cannabinoid Reserves for Product
Expansion of CBD, CBG and Host of Hemp Derived Terpenes; PhytoSPHERE Systems
Announces Creation of US Hemp Oil Corp -Its Pet Product Line- Cibdex and Skin
Care Line -Cibaderm- to be Introduced Later in the Year
SAN DIEGO, June 18, 2013 (GLOBE NEWSWIRE) -- Medical Marijuana Inc. (OTC:MJNA)
and PhytoSPHERE Systems are pleased to inform shareholders and the general
public that the company has expanded hemp production significantly. With the
expansion, the company has increased production of the industry's first
natural pharmaceutical-grade CBD-rich oils and derivatives. The increased
capacity to 6,000 tons of raw base material from 2,000 tons will make
PhytoSPHERE Systems one of the largest hemp production companies in the world.
PhytoSPHERE Systems has recently created US Hemp Oil Corp, which is currently
developing the Pet industries first CBD-based Pet Care product line- "Cibdex"
as well as an exclusive CBD-cannabinoid Skin Care Line aptly named "Cibaderm".
Increase of Hemp Production to an estimated 6,000 Tons for 2013 Harvest
PhytoSPHERE Systems has informed shareholders that the company has added 4,000
tons of raw hemp to the present production capabilities of 2,000 tons. The
increase in hemp based raw materials increases the company's production
capabilities of CBD-rich oils as well as allows the company to increase its
production of other cannabinoid rich hemp oils such as Cannabigerol (CBG).
Furthermore, this production increase is expected to add the equivalent of 450
tons of Cannabinoid-rich hemp oil to overall reserves- an increase of 300
tons. With the recent licensing agreement with CannaVest Corp the opportunity
was created for this increased production which in turn lowered the overall
cost of the raw ingredients significantly. These costs savings will eventually
lead to lower sales prices for finished goods for consumers.
PhytoSPHERE to Invest in Hemp Harvesting and Product Equipment
PhytoSPHERE Systems, in order to keep up with expanding worldwide hemp
production, has announced the company will invest in a series of new hemp
harvesting and production equipment. This will allow for the added in-ground
production to be processed and handled in an efficient manner while keeping
the integrity of the supply chain intact and increasing the quality of the
PhytoSPHERE to Expand Product Capabilities into Pharmaceutical Market
PhytoSPHERE Systems has additionally announced that it will expand production
of cannabidiolic acid (CBD-A) and various terpenes/terpenoids in line with
increased demand from pharmaceutical companies and research bodies.
PhytoSPHERE will also start to produce significant quantities of a second
cannabinoid—cannabigerol (CBG). These simultaneous developments will enable
the company to explore additional combinations of products within new and
expanding product lines. Research has shown that combining various
cannabinoids and terpenoids have increased the overall effects of a single
component cannabinoid product. This effect has been coined the "Entourage
Effect". The company is positioning itself to supply large quantities of
naturally derived cannabinoids, terpenes\terpenoids to the pharmaceutical
industry as an additive\enhancing ingredient to their current product
portfolio's whereby making the products have the "Entourage Effect" or be more
effective against the companies target demographic.
PhytoSPHERE Systems US-Based Operations Expanding
PhytoSPHERE Systems expanded their US-based operations with the increase of
its office, warehouse and laboratory operations with new leases in San Diego
California and Las Vegas Nevada. The company is still actively recruiting and
hiring new team members in customer services and sales.
PhytoSPHERE Announces the Creation of US Hemp Oil- as well as Fitness, Pet and
Skin Care Lines
PhytoSPHERE has formed a new entity US Hemp Oil Corp. US Hemp Oil is focused
on the development and production of hemp based products, including hemp
protein products, hemp seed oil, hemp based omega products. The company also
formed two additional business units Cibdex and Cibaderm. Cibdex is the
world's first hemp CBD-based Pet product line and Cibaderm is exclusively
focused on CBD and other Cannabinoid rich skin care products. The company
expects to launch its full line of products over the course of 2013.
"The industry is expanding quickly, research in the area of cannabinoids and
terpenes are on the forefront of an industry shift. By the expansion of hemp
based raw materials for specialty hemp oil and compounds, the company
continues to be an industry leader and innovator. We are extremely proud of
the position of the company and look forward to seeing our businesses mature
as the industry does. I would like to thank our shareholders for their
continued support and the support of our dedicated team." Said Michelle
Sides, Chairman and COO of Medical Marijuana Inc.
About PhytoSPHERE Systems
PhytoSPHERE Systems is a global phyto-cannabinoid biotechnology company based
in San Diego, California with operations on several continents. The company
utilizes advanced cultivation methods and state-of-the-art processing
technology leading to development of pharmaceutical, nutraceutical and food
For more information on PhytoSPHERE, visit: www.phytospheresystems.com
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators,
leveraging our team of professionals to source, evaluate and purchase
value-added companies and products, while allowing them to keep their
integrity and entrepreneurial spirit. We strive to create awareness within
our industry, develop environmentally friendly, economically sustainable
businesses, while increasing shareholder value. For more information, please
visit the company's website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is
subject to the Safe Harbor created by those sections. This material contains
statements about expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such
forward-looking statements by definition involve risks, uncertainties and
other factors, which may cause the actual results, performance or achievements
of Medical Marijuana, Inc. to be materially different from the statements made
CONTACT: Corporate Contact:
Medical Marijuana, Inc.
Tel: 888-OTC-MJNA (888-682-6562)
Cannavest Corp. Contact:
Investor Relations Contact:
Stuart T. Smith
Press spacebar to pause and continue. Press esc to stop.